影响3%高渗盐水雾化吸入治疗毛细支气管炎患儿疗效的多因素分析被引量：21

Multivariate analysis of efficacy of nebulized inhalation of 3% hypertonic saline in pediatric inpatient with bronchiolitis

下载PDF

导出

摘要目的探讨3%高渗盐水雾化吸入治疗毛细支气管炎的有效性及影响其疗效的因素。方法回顾性分析2009年6月至2012年12月住院患儿中首要诊断为毛细支气管炎且已完善鼻咽抽吸物16种常见呼吸道病毒检测的病例资料。以治疗2天后临床严重程度评分下降百分比和住院时间作为终点指标评价3%高渗盐水雾化吸入治疗的有效性,并进一步寻找影响其疗效的因素。结果 3%高渗盐水雾化吸入治疗组患儿2天后严重程度评分平均下降42.86%（11.11%-66.67%）,显著高于未使用高渗盐水治疗组的平均下降率26.79%（0%-50.00%）,差异有统计学意义（P=0.006）;两组患儿住院时间差异无统计学意义（P=0.26）。多重线性回归分析显示,年龄〉3个月、母乳喂养、呼吸道合胞病毒（RSV）感染及肺部听诊可闻及广泛哮鸣音的患儿疗效更好,该多重线性回归分析模型具有统计学意义（R2=0.58,P3个月、母乳喂养、RSV感染、肺部闻及广泛哮鸣音的毛细支气管炎住院患儿,疗程为2-3天。 Objective To evaluate the efficacy and influencing factors of 3% hypertonic saline（HS） inhalation in treatment of bronchiolitis.Methods Clinical data together with the detection of 16 types of respiratory tract virus from hospitalized pediatric patients with primary diagnosis of bronchiolitis from June 2009 to December 2012 were retrospectively analyzed.The endpoint indicators for evaluation on the efficacy of nebulized 3% HS inhalation were the percent decrease of clinical severity（CS） score after 2 days＇ treatment and the hospitalization time.Factors affecting efficacy were further explored.Results The CS score in nebulized 3% HS treated group decreased in average of 42.86%（11.11%-66.67%）,significantly higher than that（26.79%,0.00%-50.00%） in the untreated group（P=0.006）.No difference of between the two groups（P=0.26）.Multiple linear regression analysis showed that nebulized 3% HS inhalation has better efficacy on the patients older than 3 months having breastfeeding,respiratory synthetic syncytial virus（RSV） infection and extensive wheezing sound auscultation of the lungs.The multiple linear regression analysis model was statistically significant（R2=0.58,P〈0.001）.Conclusions After 2 days＇ treatment with 3% hypertonic saline inhalation,the CS score of bronchiolitis patients was decreased.The treatment can be recommended in hospitalized patient older than 3 months with breastfeeding,RSV infection,and extensive wheezing sound auscultation of the lungs.

作者陈思思任洛罗健罗征秀刘恩梅

机构地区重庆医科大学附属儿童医院

出处《临床儿科杂志》 CAS CSCD 北大核心 2016年第2期88-92,共5页 Journal of Clinical Pediatrics

基金国家科技重大专项(No.2013ZX10004202-002) 国家临床重点专科(No.2011[873]) 重庆医科大学附属儿童医院转化医学专项(No.(2013)33-zhyx2013-5)

关键词毛细支气管炎高渗盐水影响因素儿童 bronchiolitis hypertonic saline solution multivariate predictors child

分类号 R725.6 [医药卫生—儿科]

引文网络
相关文献

参考文献23

1Calvo C, Pozo F, Garcia-Garcia ML, et al. Detection of new respiratory viruses in hospitalized infants with bronchi- olitis: a three-year prospective study [J]. Acta Paediatr, 2010, 99 (6): 883-887.
2American Academy of Pediatrics Subcommittee on Diagno- sis and Management of Bronchiolitis. Diagnosis and man- agement of bronchiolitis [J]. Pediatrics, 2013, 118 (4): 1774-1793.
3Mesquita M, Castro-Rodriguez JA, Heinichen L, et al. Single oral dose of dexamethasone in outpatients with bron- chiolitis: a placebo controlled trial [J]. Allergol Immuno- pathol(Madr), 2009, 37(2): 63-67.
4Fernandes RM, Bialy LM, Vandermeer B, et al. Gluco- eorticoids for acute viral bronchiolitis in infants and young children [DB/OL]. Cochrane Database Syst Rev, 2013, 6. CD004878.
5Plint AC, Johnson DW, Patel H, et al. Epinephrine and dexamethasone in children with bronchiolitis [J]. N Engl J Med, 2009, 360(20): 2079-2089.
6Gadomski AM, Scribani MB. Bronchodilators for bronehio- litis [DB/OL]. Cochrane Database Syst Rev, 2014, 6. CD001266.
7Davison C, Ventre KM, Luchetti M, et al. Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis [J]. Pediatr Crit Care Med, 2004, 5 (5): 482-489.
8Eng PA, Morton J, Douglass JA, et al. Short-term effi- cacy of ultrasonically nebulized hypertonic saline in cystic fibrosis[J].PediatrPulmonol, 1996, 21(2): 77-83.
9Robinson M, Hemming AL, Regnis JA, et al. Effect of increasing doses of hypertonic saline on mucociliary clea- rance in patients with cystic fibrosis [J]. Thorax, 1997, 52(10): 900-903.
10Mandelberg A, Tal G, Witzling M, et al. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis [J]. Chest, 2003, 123(2): 481-487.

二级参考文献16

1Nair H,Nokes DJ,Gessner BD. Global burden of acute lower respiratory infections due to respiratory.syncytial virus in young children:a systematic review and meta-analysis[J].The Lancet,2010,(9725):1545-1555.
2Evertsen J,Baumgardner D J,Regnery A. Diagnosis and management of pneumonia and bronchitis in outpatient primary care practices[J].PRIMARY CARE RESPIRATORY JOURNAL,2010,(03):237-241.
3杨锡强;易著文.儿科学[M]北京:人民卫生出版社,2004307-316.
4Miedinger D,Neukomm E,Chhajed PN. The use of the asthma control test in general practice and its correlation with asthma control according to the GINA guidelines[J].Current Medical Research and Opinion,2011,(12):2301-2308.
5Dina J,Vabret A,Gouarin S. Detection of human bocavirus in hospitalised children[J].Journal of Paediatrics and Child Health,2009,(03):149-153.
6Escobar GJ,Ragins A,Li SX. Recurrent wheezing in the third year of life among children born at 32 weeks' gestation or later:relationship to laboratory-confirmed,medically attended infection with respiratory syncytial virus during the first year of life[J].Archives of Pediatrics and Adolescent Medicine,2010,(10):915-922.
7Carroll KN,Wu P,Gebretsadik T. The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma[J].Journal of Allergy and Clinical Immunology,2009,(05):1055-1061.
8Murawski MR,Mcginnes LW,Finberg RW. Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice,with no evidence of immunopathology[J].Journal of Virology,2010,(02):1110-1123.
9Sim(o)es EA,Carbonell-Estrany X,Rieger CH. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children[J].Journal of Allergy and Clinical Immunology,2010,(02):256-262.
10Olszewska W,Zambon M,Openshaw PJ. Development of vaccines against common colds[J].British Medical Bulletin,2002.99-111.